NCT00140881View on ClinicalTrials.gov

A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2000

Primary Completion Date

February 14, 2003

Study Completion Date

February 14, 2003

Conditions
Asthma
Interventions
DRUG

MK0476; montelukast sodium

DRUG

Comparator: placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00140881 - A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165) | Biotech Hunter | Biotech Hunter